← Back to Search

Speech Exposure for Autism

N/A
Waitlist Available
Research Sponsored by New York University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Must not have
born premature (< 36 weeks)
has a history of photosensitive epileptic seizures
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after 5 minutes
Awards & highlights
No Placebo-Only Group

Summary

This trial is looking to see if children with ASD can learn word meanings from overheard conversations, and if so, what child characteristics are associated with good learning in this situation.

Who is the study for?
This trial is for children aged 18 to 71 months, with or without Autism Spectrum Disorder (ASD). They must be native English speakers and not have been born prematurely. Children with uncorrected hearing or vision issues, photosensitive epileptic seizures, or other developmental disorders affecting language/cognition are excluded.
What is being tested?
The study examines how well children with ASD can learn new words from conversations they overhear compared to being directly taught. It will also check if these learned words are remembered after a short time and can be used in different situations.
What are the potential side effects?
Since this trial involves educational interventions like addressed speech and overheard speech rather than medical treatments, there aren't typical side effects as seen in drug trials. However, participants may experience varying levels of engagement or stress.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I was born before 36 weeks of pregnancy.
Select...
I have had seizures triggered by flashing lights.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of children who select the target object by touching, pointing, or grasping
Number of children who select the target object by touching, pointing, or grasping on each trial

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: OverheardExperimental Treatment1 Intervention
Children are present in the room while an experimenter uses the word to be learned in an interaction with another experimenter.
Group II: AddressedActive Control1 Intervention
Children participate in an interaction with an experimenter who uses the word to be learned.

Find a Location

Who is running the clinical trial?

Emerson CollegeUNKNOWN
4 Previous Clinical Trials
571 Total Patients Enrolled
2 Trials studying Autism Spectrum Disorder
474 Patients Enrolled for Autism Spectrum Disorder
New York UniversityLead Sponsor
241 Previous Clinical Trials
220,168 Total Patients Enrolled
3 Trials studying Autism Spectrum Disorder
1,474 Patients Enrolled for Autism Spectrum Disorder

Media Library

Addressed Speech Clinical Trial Eligibility Overview. Trial Name: NCT04166591 — N/A
Autism Spectrum Disorder Research Study Groups: Addressed, Overheard
Autism Spectrum Disorder Clinical Trial 2023: Addressed Speech Highlights & Side Effects. Trial Name: NCT04166591 — N/A
Addressed Speech 2023 Treatment Timeline for Medical Study. Trial Name: NCT04166591 — N/A
~3 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top